Emergent BioSolutions Collaborates with WHO and U.S. Government to Combat Mpox Outbreak in Central Africa

Active engagement with the World Health Organization, U.S. government and other global health leaders on critical efforts to prevent mpox disease ...

August 20, 2024 | Tuesday | News
Pfizer and BioNTech's Ambitious Combo Vaccine Shows Promise but Faces Hurdles in Phase 3 Trial

In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicit...

August 19, 2024 | Monday | News
Phanes Therapeutics Secures FDA Orphan Drug Designation for PT217 in Treating Neuroendocrine Carcinoma

Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, announced today th...

August 19, 2024 | Monday | News
Agilent Unveils Next-Generation J&W 5Q GC/MS Columns, Elevating Industry Standards in Chromatography

Agilent Technologies Inc.,  announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...

August 16, 2024 | Friday | News
Thermo Fisher’s PPD Clinical Research Business Recognized as Industry Leader in Digital Services by ISG

The PPD clinical research business of Thermo Fisher Scientific, the world leader in serving science, has been honored for industry leadership in digital ...

August 15, 2024 | Thursday | News
Gilead Sciences Announces FDA Accelerated Approval for Livdelzi® in Treating Primary Biliary Cholangitis

Gilead Sciences, Inc.  announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Livdelzi® (seladelpar) fo...

August 15, 2024 | Thursday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News
Renexxion and Dr. Falk Pharma Begin U.S. Patient Dosing in Global Phase 2b Study for Promising Gastroparesis Treatment

Renexxion Ireland Limited (“Renexxion”), a private biopharmaceutical company committed to delivering innovative drugs to patients with high u...

August 14, 2024 | Wednesday | News
Persist AI and Nivagen Announce Strategic Collaboration to Transform Long-Acting Injectable Drug Manufacturing

Persist AI and Nivagen have announced a collaboration to co-develop a next-generation manufacturing process for long-acting injectable (LAI) drugs, ...

August 13, 2024 | Tuesday | News
Ascendis Pharma’s YORVIPATH® Offers Continuous PTH Therapy, Meeting Critical Needs of Over 70,000 U.S. Hypoparathyroidism Patients

Hypoparathyroidism is a rare endocrine disease with multi-organ impacts affecting an estimated 70,000 to 90,000 people in the United States Ascendi...

August 12, 2024 | Monday | News
MSD Discontinues Phase 3 KeyVibe-008 Trial for Extensive-Stage Small Cell Lung Cancer

Merck (NYSE: MRK), known as MSD outside of the United States and Canada,  announced the discontinuation of the Phase 3 KeyVibe-008 trial based on th...

August 09, 2024 | Friday | News
Daiichi Sankyo and MSD Expand Collaboration to Co-Develop and Co-Commercialize DLL3 T-Cell Engager MK-6070

Agreement builds on and complements Daiichi Sankyo and Merck’s shared commitment to develop novel medicines for patients with cancer Daiichi Sanky...

August 07, 2024 | Wednesday | News
Baylor Genetics and Baylor College of Medicine Launch New Lab to Advance Clinical Diagnostics

Baylor Genetics, a joint venture clinical diagnostic laboratory at the forefront of genetic testing, and the Department of Molecular and Human Genetics a...

August 06, 2024 | Tuesday | News
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy

Agilent that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying patients with synovia...

August 05, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close